Effects of Long Biliopancreatic Limb Versus Long Alimentary Limb in Superobesity, a Randomized Study
NCT ID: NCT02033577
Last Updated: 2015-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2011-08-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study aims at clarifying possible differences in effects and side-effects of these two surgical-technical variations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study
NCT01514799
Long-limb or Distal Gastric Bypass for Superobesity - Randomized Study
NCT00821197
Effect of Long Biliopancreatic Limb RYGB on Weight Loss and Comorbidities
NCT01686997
A Comparison Between Short vs. Long Biliopancreatic Limb Gastric Bypass
NCT04609449
Gastric Bypass With Different Lengths of the Bilipancreatic Limb
NCT05334173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Perioperative biopsies to assess mucosal properties at the gastrojejunostomy and the enteroanastomosis. Repeat biopsies (gastroscopy) at one year to identify changes in the mucosa at the Gastroenteroanastomosis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Distal gastrojejunal bypass
RYGB with 200 cm BP limb and 150 cm common limb
Distal gastrojejunal bypass
RYGB with 200 cm BP limb and 150 cm common limb, effect on EWL, QoL and complications
RYGB
RYGB with 60 cm BP limb and 150 cm alimentary limb
RYGB
RYGB with 60 cm BP limb and 150 cm alimentary limb, effect on
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Distal gastrojejunal bypass
RYGB with 200 cm BP limb and 150 cm common limb, effect on EWL, QoL and complications
RYGB
RYGB with 60 cm BP limb and 150 cm alimentary limb, effect on
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Inflammatory bowel disease
* inability to understand Swedish
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Aleris Obesity
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan Hedenbro
Senior scientist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aleris Obesity
Lund, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jan Hedenbro
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCT01514799
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.